All Medical News

• 

  All Medical News

  ISH/BSH 2016: Dr Craig Moskowitz (Memorial Sloan Kettering Cancer Center, NY, USA) and Professor David Linch (University College London Hospital) discuss the role of transplant in HL. Also included an associated article entitled ‘Allogeneic stem cell transplantation: still a role in CLL/lymphoma?’

  Written by Christine Clark | 6 Jun 2016

  Allogeneic stem cell transplantation: still a role in CLL/lymphoma? by Christine Clark Professor Peter Dreger, Heidelberg University Hospital, Germany. The goal of allogeneic transplant therapy is to provide… read more.

• 

  All Medical News

  ISH/BSH 2016: Professor Keith Stewart (Mayo Clinic, USA) discusses current dilemmas in MM, not least of which is how to manage patients with the ever growing number of new agents. He discusses the Mayo Clinic algorithm, whilst Professor Paul G. Richardson (Dana-Farber, USA) discusses the Dana-Farber algorithm for managing MM

  Written by Lorraine Carolan | 3 Jun 2016

• 

  All Medical News

  ISH/BSH 2016 Abstracts and Posters: Results from the NCRI Myeloma XI trial

  Written by Lorraine Carolan | 3 Jun 2016

  Charlotte Pawlyn and John R Jones (both of Institute of Cancer Research, London) and Ruth de Tute, St James’s University Hospital, Leeds. by Maria Dalby: Quadruplet therapy with… read more.

• 

  All Medical News

  ISH/BSH 2016: Professor Philippe Moreau from Nantes in France reviewed the rationale for the new diagnostic criteria and highlighted the gaps in current risk models for stratifying the risk of progression to MM… Also included article entitled ‘High-risk smouldering myeloma’

  Written by Lorraine Carolan | 2 Jun 2016

  High-risk smouldering myeloma by Maria Dalby Professor Philippe Moreau, University Hospital Hôtel-Dieu, Nantes, France Subsequent to the publication of updated diagnostic criteria for MM in 2014,1 MM clinicians have… read more.

• 

  All Medical News

  ISH/BSH 2016: Advances in our understanding of clonal evolution in MM: where are we now?

  Written by Lorraine Carolan | 2 Jun 2016

  Professor Keith Stewart, Mayo Clinic, Scottsdale, AZ, USA. by Maria Dalby: The dramatic improvement in MM survival in the last 40 years is largely linked to the introduction… read more.

• 

  All Medical News

  ISH/BSH 2016: Professor Keith Stewart (Mayo Clinic, USA) discusses his presentation from the presidential session on genomic sequencing in this video. Also included article entitled ‘Genome-guided therapy in multiple myeloma’

  Written by Lorraine Carolan | 1 Jun 2016

  Genome-guided therapy in multiple myeloma by Maria Dalby Professor Keith Stewart, Mayo Clinic, Scottsdale, AZ, USA Genomic sequencing of newly-diagnosed and refractory MM patients shows that combination therapy… read more.

• 

  All Medical News

  ISH/BSH 2016: Professor Graham Jackson (Newcastle-Upon-Tyne, UK) discusses the risk factors and patient characteristics that most inform treatment selection for patients with R/R MM. Also included article ‘Risk stratification in the older patient: what are our priorities?’

  Written by Lorraine Carolan | 31 May 2016

  Risk stratification in the older patient: what are our priorities? by Maria Dalby Professor Sonja Zweegman, VU University Medical Centre, Amsterdam, NL Biological age and frailty, rather than… read more.

• 

  All Medical News

  ISH/BSH 2016: Professor Graham Jackson (Newcastle-Upon-Tyne, UK) discusses the risk factors and patient characteristics that most inform treatment selection for patients with R/R MM. Also included article 'Risk stratification in the older patient: what are our priorities?'

  Written by Lorraine Carolan | 31 May 2016

  Risk stratification in the older patient: what are our priorities? by Maria Dalby Professor Sonja Zweegman, VU University Medical Centre, Amsterdam, NL Biological age and frailty, rather than… read more.

• 

  All Medical News

  ISH / BSH 2016: A well attended joint ISH / BSH meeting in Glasgow brought together cutting edge research from both the UK and international myeloma community, whilst allowing lively debate on how best to implement recent advances within the environment of the NHS. Professor Paul G. Richardson (Boston, USA) and Professor Graham Jackson (Newcastle-Upon-Tyne, UK) give an international and British perspective on highlights from the meeting.

  Written by Lorraine Carolan | 30 May 2016

• 

  All Medical News

  ISH / BSH 2016: Professor John Radford (The University of Manchester), Dr Graham Collins (Oxford University Hospitals) and Professor David Linch ( University College Hospital, London) give their highlights from this year’s BSH meeting in association with the 36th World Congress of the International Society of Hematology.

  Written by Lorraine Carolan | 30 May 2016

• 

  All Medical News

  ‘Valuable collaboration’ between drug regulators and HTA bodies

  Written by Gary Finnegan | 27 May 2016

  by Gary Finnegan: Cooperation between medicines regulators and health technology assessment (HTA) bodies is helping to streamline clinical studies of new medicines, according to a new report.

• 

  All Medical News

  Drug watchdog: ‘Adult data can be used for children’s medicines’

  Written by Gary Finnegan | 27 May 2016

  by Gary Finnegan: The European Medicines Agency (EMA) has published a draft version of a new paper on how to extrapolate clinical trial data from adults to children…. read more.